RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Headshot of Sara Maloney Norcross

Sara Maloney Norcross

Research Chemist


Ph.D., Analytical Chemistry, University of North Carolina at Chapel Hill
B.S., Chemistry and Forensic Chemistry, Towson University


Sara Maloney Norcross is a research chemist at RTI, where she serves as a principal investigator and co-investigator for multiple programs related to inhaled drug formulation and delivery. Many of these programs focus on the preparation of inhaled therapeutics to treat pulmonary infections, including those caused by Mycobacterium tuberculosis, nontuberculous mycobacteria, and pan-drug resistant bacteria. Dr. Maloney Norcross is currently working to formulate a novel intranasal vaccine for tuberculosis. 

Prior to joining RTI in 2022, Dr. Maloney Norcross completed her Ph.D. at the University of North Carolina at Chapel Hill, where she developed nitric oxide-releasing biopolymers and formulations to treat chronic wound infections and prevent catheter-related bloodstream infections. 

Get in Touch

To speak to this expert or inquire about RTI services, you can reach us at +1 919 541 6000 or use the contact form below. For media inquiries, please reach out to our Media Relations team at news@rti.org.

Blue background circle graphics